In the present study, we engineered miR-302a-loaded EVs derived from hUCMSCs and demonstrated that these miR-302a-loaded EVs could significantly inhibit the cell proliferation and migration through reduction of cyclin D1 expression and suppression of AKT signaling pathway in endometrial cancer cells. This evidence concerns the gene AKT1 and endometrial cancer.